Cover Image
市場調查報告書

Alligator Bioscience AB:產品平台分析

Alligator Bioscience AB - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192454
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Alligator Bioscience AB:產品平台分析 Alligator Bioscience AB - Product Pipeline Review - 2015
出版日期: 2015年04月30日 內容資訊: 英文 29 Pages
簡介

Alligator Bioscience AB 是基於治療癌症用免疫療法來開發抗體的生物科技企業。該公司活用獨家的片段技術平台和人體體庫,以開發新藥物。

本報告提供Alligator Bioscience AB 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Alligator Bioscience AB的基本資料

  • Alligator Bioscience AB概要
  • 主要資訊
  • 企業資料

Alligator Bioscience AB:R&D概要

  • 主要的治療範圍

Alligator Bioscience AB:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Alligator Bioscience AB:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Alligator Bioscience AB:藥物簡介

  • ADC-1013
  • ADC-1004
  • ADC-1014
  • ADC-1015
  • Proteins for Undisclosed Indication
  • ADC-1016

Alligator Bioscience AB:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Alligator Bioscience AB:最近的開發平台趨勢

Alligator Bioscience AB:暫停中的計劃

Alligator Bioscience AB:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07017CDB

Summary

Global Markets Direct's, 'Alligator Bioscience AB - Product Pipeline Review - 2015', provides an overview of the Alligator Bioscience AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Alligator Bioscience AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Alligator Bioscience AB including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Alligator Bioscience AB's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Alligator Bioscience AB's pipeline products

Reasons to buy

  • Evaluate Alligator Bioscience AB's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Alligator Bioscience AB in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Alligator Bioscience AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Alligator Bioscience AB and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Alligator Bioscience AB
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Alligator Bioscience AB and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Alligator Bioscience AB Snapshot
    • Alligator Bioscience AB Overview
    • Key Information
    • Key Facts
  • Alligator Bioscience AB - Research and Development Overview
    • Key Therapeutic Areas
  • Alligator Bioscience AB - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Alligator Bioscience AB - Pipeline Products Glance
    • Alligator Bioscience AB - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Alligator Bioscience AB - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Alligator Bioscience AB - Drug Profiles
    • ADC-1013
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADC-1004
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADC-1014
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADC-1015
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Proteins for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADC-1016
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Alligator Bioscience AB - Pipeline Analysis
    • Alligator Bioscience AB - Pipeline Products by Target
    • Alligator Bioscience AB - Pipeline Products by Route of Administration
    • Alligator Bioscience AB - Pipeline Products by Molecule Type
    • Alligator Bioscience AB - Pipeline Products by Mechanism of Action
  • Alligator Bioscience AB - Recent Pipeline Updates
  • Alligator Bioscience AB - Dormant Projects
  • Alligator Bioscience AB - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Alligator Bioscience AB, Key Information
  • Alligator Bioscience AB, Key Facts
  • Alligator Bioscience AB - Pipeline by Indication, 2015
  • Alligator Bioscience AB - Pipeline by Stage of Development, 2015
  • Alligator Bioscience AB - Monotherapy Products in Pipeline, 2015
  • Alligator Bioscience AB - Partnered Products in Pipeline, 2015
  • Alligator Bioscience AB - Partnered Products/ Combination Treatment Modalities, 2015
  • Alligator Bioscience AB - Phase I, 2015
  • Alligator Bioscience AB - Preclinical, 2015
  • Alligator Bioscience AB - Discovery, 2015
  • Alligator Bioscience AB - Pipeline by Target, 2015
  • Alligator Bioscience AB - Pipeline by Route of Administration, 2015
  • Alligator Bioscience AB - Pipeline by Molecule Type, 2015
  • Alligator Bioscience AB - Pipeline Products by Mechanism of Action, 2015
  • Alligator Bioscience AB - Recent Pipeline Updates, 2015
  • Alligator Bioscience AB - Dormant Developmental Projects,2015

List of Figures

  • Alligator Bioscience AB - Pipeline by Top 10 Indication, 2015
  • Alligator Bioscience AB - Pipeline by Stage of Development, 2015
  • Alligator Bioscience AB - Monotherapy Products in Pipeline, 2015
  • Alligator Bioscience AB - Pipeline by Top 10 Target, 2015
  • Alligator Bioscience AB - Pipeline by Top 10 Route of Administration, 2015
  • Alligator Bioscience AB - Pipeline by Top 10 Molecule Type, 2015
  • Alligator Bioscience AB - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top